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be considered in individuals with CVD risk factors or established CVD to identify and 
treat those with diabetes. The results of the NAVIGATOR trial will indicate whether treat- 
ment of those with IGT can reduce their CVD risk. 
1169-52 Low Socioeconomic Status Is More Predictive of 
Increased Hazard in Women Than Men After 
Angiographic Diagnosis of Coronary Artery Disease 
Sandra P. Revna Joseph B. Muhlestem, Benjamin D. Home, Tami L. Bair, Chloe A. 
Allen Maycock, Robert R. Pearson, Stephanie V. Moore, Dale G. Renlund, Jeffrey L. 
Anderson, LDS Hospital, Salt Lake City, UT, University of Utah, Salt Lake City, UT 
Background: Low socioeconomic status (SES) has been associated with an increased 
risk of coronary heart disease. We previously demonstrated that a geographic-based sur- 
rogate measure of SES, residential economic status @ES), predicts the risk of coronary 
events among patients with CAD. However, the impact of SES might differ by gender. 
Methods: Between 1993 and 1999, a cohort of 7,147 patients (men [n=5,310]. average 
age: 64+11 years; women [n=l,837], average age: 68i12 years) with advanced, angle- 
graphically-defined CAD (>70% stenosis) was evaluated for RES and outcome by gen- 
der. RES was determined by the median household income (1990 US Census) of each 
patient’s residential zip code. Twenty-two demographic variables, cardiac risk factors, 
clinical variables, and treatment therapies were also recorded at baseline. Proportional 
hazards regression was used to examine the risk of incident CAD events, defined as 
death and nonfatal myocardial infarction (Ml), over an average follow-up of 3.4e2.0 yrs 
(maximum, 7.3 years). 
Results: Overall event rates were 33.2% for wcmen and 27.6% for men (p<O.OOl). A 
significant inverse association was observed between quintiles of RES and incident CAD 
for both women (32.8%, 32.9%, 30.8%. 22.9% 24.3%; P-trend=O.OOl) and me” (25.3%, 
24.3% 23.6%, 22.2%, 20.2%; P-trend<O.OOl). but the effect of low RES was amplified in 
wmen with an apparent threshold. Low RES was associated with an adjusted relative 
hazard (RH) of incident death/Ml of 1.47 (95% Cl=1.23-1.75) in women versus 1.14 (95% 
CI=l.OZ-1.27) in men, comparmg RES quintiles 1-3 with quintiles 4-5. The interaction 
between gender and RES on death/Ml was significant (adjusted p-value for interaction = 
O.O4S).Conclusion: Lower RES predicts incident coronary events rn women as well as 
men with CAD. Indeed, low RES was found to pose a greater hazard in women. Further 
studies, which include precise measures of SES, are now indicated to define the gender- 
related and other factors causing these poor wtcOmes in subjects with low SES. 
1169-53 Effect of Ethnicity on Long-Term Outcomes Following 
Percutaneous Coronary intervention in a Setting With 
Universal Access to Health Care 
Linda L. Huffer, Robert E. Eckart, Eric A. Shry. Jose A. DeHoyos, Daniel E. Simpson, 
Brooke Army Medical Center, Fort Sam Houston, TX 
Background: We sought to examine the role of ethnicity in those undergoing percutane- 
ous coronary intervention (PCI) in a health care system in which there is universal 
access. Methods: We retrospectwely rewewed all percutaneous interventions performed 
on Caucasians, African Americans. or HIspanics from 1 Jan1 998 to 1 lAug2001 at Brooke 
Army Medical Center. Data in a centralwed database included patient co-morbidities, 
angiography and intervention findings, and post-PC1 pharmacologic interventions. One 
year following the procedure, subjects were reassessed for death, need for surgical or 
percutaneous revascularizatlon, and biochemical evidence of myocardial mjury. Results: 
There were 933 mterventlons performed on 888 subjects (Caucasian n=719,African- 
Amertcan w77,Hrspanic n=92) wer the specified time period. The mean age of African 
Americans was lower than Caucasians (60.3+10 3 vs 64.5+11 .1,95% Cl 1.6-6.8) with a 
similar mcidence of diabetes (33.8%~~ 27.7%.p=O.32) and an equivalent ejection fraction 
(52.7~14.1~~52.5~13.1, p=O.91). Compared to Caucasians, African Americans were 
more likely to undergo revascularization withln one-year (24.7%vsl4.2%,p=O.O2) and die 
(14.5%vs6.6%,p=O.O2). When controlled for age, ejectron fraction, presentation for acute 
myocardlal infarctlon, and hrstory of diabetes, African-American race was a statistically 
significant risk factor for death (OR 3.97, 95% Cl 1.50-10.54). When stent implantation 
was added to the multivariate analysis for death, African-American race remained a sig- 
nificant predictor (OR 4.28.95% Cl 1.56-11.73). Compared to Caucasians, Hispanics 
showed no differences in revascularization. myocardial injury, or death. Conclusions: 
Although there were procedural differences noted I” subjects of differing ethnicity. this 
did not explain the increased mortality I” African Americans in a system with equal 
access to care. 
1169-54 Value of Routine Holter Screening for the Detection of 
Paroxysmal Atrial Fibrillation in Patients With Cerebral 
lschemic Attacks 
Beat A. Schaer. Thomas A. Cron, Stefan Oswald, University Hospital, Basel. 
Switzerland 
Background: Halter-monrtoring for the detectjon of paroxysmal atrial fibrillation (PAF) in 
addition to echocardiography and carotic Doppler is a routine procedure after cerebral 
ischemic attacks (CIA), although the reported incidence of PAF is low and the value of 
Halter with this indication unknown. Aim of this study was to evaluate the incidence of 
PAF, to assess the Impact of Its diagnosis on drug regimen mcdiflcation (DRM) and to 
calculate the cost-effectiveness of Halter as a screenmg test. 
Methods: All bolters and ethos (lTETTEE) of pts with CIA, referred to our clinic for the 
evaluation of a possible thromboembolic source, were analyzed by two cardiologists. 
PAF was defined as at least 20 consecutive arrhythmlc ventricular beats (RR-interval 
irregularity .25%). 
Results: Between OllOO and 06102, 308 pts (age 35 to 92y, median 68) had a routine 24 
hour-Halter after CIA (17% of all Halters). PAF was diagnosed in 9 pts (3%): in 2 pts 
anticoagulation (AC) was refused or contraindicated: 2 pts were on AC and PAF was 
already documented on a lzlead-ECG; 1 pt had a carotic stenosis > 90% as an addi- 
tional risk factor for CIA; 1 pt had PAF, but was on AC for a basilar thrombosis; 1 had 
PAF before and therefore was on ASS; in 2 pts, a new diagnosis of PAF was established. 
The last 3 pts were put on AC after Halter, resulting in 3/308 (1%) DRM. Given the costs 
of 150 $ per Halter. there were overall expenses of 46’200 $. that is 5’130 $ per PAF or 
15’400 5 per DRM. The “number-needed-to-investigate” was 102 Halters for one DRM. 
In 270 pts, echocardtography was performed (144 TTE, 76 TEE, 50 TTWEE). In 86 
(32%) pts a potential swrce of emboksm was detected (slgndicant plaques 55%, for- 
mane wale 36%, other 9%). Conclusions: Our data demonstrate that PAF in CIA- 
patients: 1) has a low incidence 2) if diagnosed, hardly leads to a drug modification 3) 
has high per-case-costs. Therefore, routine Halter screening is not recommended in pts 
with CIA. On the other hand, echocardlography has a much higher yield to detect possi- 
ble abnormalities responsible for a CIA. 
1169-55 Effect of Green Tea Intake on the Development of 
Coronary Artery Disease 
Junk0 Sane, Tomohiro Ogawa, Shigenobu Inami, Fumiyuki Ishibashi. Kentaro 
Okamatsu, Hiroyuki Kamon, Kouji Selmiya, Gen Takagi, Shunta Sakai, Atsunobu 
Nomura. Kyoichl Mizuno, Chiba Hokusoh Hospital, Nippon Medical School, Chlba, Japan 
Background Japanese have a low incidence of coronary artery diseases (CAD), 
although plasma cholesterol levels and the incidence of diabetes mellltus are not differ- 
ent between Japan and Western counties and the frequency of smoking is high in Japan. 
The daily intake of food and green tea, which contains many polyphenolic antioxidants, 
are considered to be the low incidence of CAD. To determine the influence of diet on 
CAD, we analyzed the relationship between the dietary habits and the incidence of CAD. 
Methods This study comprised 309 patients (pts) who underwent coronary angiography 
(180 pts with CAD and 129 pts without CAD). Coronary risk factors, serum Itpids, daily 
intake of green tea and red wine, vitamin supplementation (C and E) and dietary habits 
(vegetable, fruits, soy beans and fish), were assessed The predictors for CAD were ana- 
lyzed by multlvariate logtstic regression analysis. 
Results The daily intake of green tea (cups/day) was significantly higher in pabents 
without CAD than in those with CAD (5.6k3.9 vs. 3.1t4.0; p=O.OOO). Independent predic- 
tors based on multlvariate analysis were green tea, vegetable, male, age, diabetes melli- 
tus (DM), hyperlipidemia (HL), and smoking. 
Conclusions The more green tea patients intake, the lesser CAD occur. Ingestion of 
green tea and vegetable are responsible, in part, for the low incidence of CAD in the Jap- 
anese population despite high incidence of cigarette smoktng. Tea consumption may be 
much useful than vegetable to prevent coronary artery disease. 
Tsa Vegetable Male Age DM HL Smokin 
g 
(per cup/ (per time/ 
day) day) 
Odds 0.85 0.73 3.25 1.07 2.14 2.47 1.97 
Ratio 
98% Cl 0.78-0.93 0.57-O 94 1.64- 1.04. 1.10. 1.41. 1.09. 
6.41 1.10 4.16 4.31 3.56 
P 0.0002 0.0129 0.0007 0.0000 0 0248 0.0015 0.0246 
1169-56 Gender Differences in Survival After Admission for 
Acutely Decompensated Heart Failure 
Doron Aronsoq Darlene P. Horton, Andrew J. Burger, Rambam Medical Center, Haifa, 
Israel. Beth Israel Deaconess Medical Center, Boston, MA 
Introduction: Natural history studies on patients with congestive heart failure have sug- 
gested that the prognosis of women is better than that for men. However, it IS not known 
whether female surwval advantage extends to patients with severe decompensated 
heart failure. 
Methods: We studied 560 patients (mean age 63 * 14 years, 377 male) with a previous 
diagnosis of heart failure (96% with New York Heart Association functional class III or IV) 
who were admitted to hospital for decompensated heart failure. 
Results: During a mean follow-up of 343 f 185 days, 177 patients (32%) died. Kaplan- 
Meieranalys~s indicated that female patients were at a lower risk of death (Figure). A Cox 
proportional-hazards model, adjusted for age, weight, diabetes status, primary etiology of 
heart failure stratified as ischemic or nonischemic. serum sodium, serum creatinine and 
medications (ACE Inhibitors, P-blockers, digoxin, or amiodarone), showed a significant 
association between female gender and better survival following hospital discharge (RR 
= 0.66, 95% Cl 0.46-0.96, p = 0.029). Predictors of increased mortality after hospital dis- 
charge included serum sodium < 135 mmollL (RR = 1.9, 95% Cl 1.4-2.6, p = O.OOOl), 
and ischemic heart failure (RR = 1.7, 95% Cl 1.2-2.3, p = 0.002). 
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Conclusion: Women admitted with decompensated heart failure appear to have better at dosages used in standard preparations of over-the-counter multivitamins. Therefore, 
survival than men after hospital discharge. These results suggest that biological differ- the addition of beta carotene to multivitamin preparations should cease and the routine 
ences in the progression of heart failure are present even with advanced disease. use of these multivitamins by consumers should be discouraged. 
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1193-51 Treatment and Outcomes of Eastern European Patients 
With Acute Coronary Syndromes in a Multinational 
Randomized Clinical Trial 
Olaa S. Gurieva, Gene Bukhman, Sabina Murphy, Christopher P. Cannon, the OPUS- 
TIMI 16 Investigators, Ukrainian Institute of Cardiology, Kiev, Ukraine, Brigham and 
Women’s Hospital, Boston, MA 
Background: Registries and clinical trials have offered limited evidence on the transla- 
tion of non-ST segment elevation acute coronary syndrome (ACS) trial findings into local 
practices in Eastern Europe (EE). We examined differences in ACS treatment and out- 
comes between EE and other regions in OPUS TIMI-16. a randomized trial of prolonged 
oral alvcoprotein Ilb/llla inhibition. 
1169-57 A Targeted Approach to Reducing Radiation Exposure 
in the Cardiac Catheterization Laboratory 
Samir V. Germanwala Venkatraman Srinivasan, Leslie Boltey, Holly James, Alan 
Gradman, The Western Pennsylvania Hospital, Pittsburgh, PA 
Background: Exposure to ionizing radiation IS an inevitable consequence of therapeutic 
procedures performed in the catheterization laboratory. The risk of radiation-induced 
injury is dose-dependent and nurnemus injuries secondary to lengthy fluoroscopic times 
are reported annually to the Food and Drug Administration. In July 2001, we imple- 
mented a multifaceted program designed to reduce radiation exposure. 
Methods: Physicians and staff were required to demonstrate proficiency with a manda- 
tory radiation-safety curriculum. In addition, fluoroscopic exposure time was documented 
and tracked during each procedure. Operators were informed at ten-minute intervals 
beginning after 30 minutes of exposure and warned if they were approaching a pre-deter- 
mined threshold (60 minutes) associated with documented risk of radiation-induced skin 
injury. To determine the effectiveness of this program, we compared fluoroscopic times 
in 1,067 patients undergoing interventional procedures during the six-month interval 
before (n=569) and after (n=516) program implementation. 
Results: Average fluoroscopic exposure time decreased from 14.5i3.1 to 9.7i3.7 min- 
utes (pcO.O3), a reduction of 31%. Furthermore, there was a 35% reduction in the num- 
ber of patients sustaining prolonged fluoroscopic exposure (> 40 minutes). There was no 
statistical difference in baseline characteristics of the two groups or in the percentage of 
patients in whom factors expected to prolong fluoroscopic exposure time (multi-vessel 
intervention, Intravascular ultrasound, measurement of fractional flow reserve or brachy- 
therapy) were present. 
Conclusion : Didactic education and real time feedback to physicians during Interven- 
tional procedures reduced average fluoroscopic exposure times and the number of 
patients exposed to prolonged irradiation by approximately one-third. Easily replicable, 
this simple program could significantly reduce the dangers of radiation exposure during 
interventional cardiology procedures. 
1169-56 Beta Carotene Increases All-Cause Mortality and 
Cardiovascular Death: A Pooled Analysis of 
Randomized Trials 
Deepak P. Vivekananthan, Marc S. Penn, Shelly S. Sapp, Eric J. Topal, The Cleveland 
I ‘. Cknlc Foundation, Cleveland, OH 
Background: Beta carotene supplementation has been previously found to be associ- 
ated with adverse outcomes in patients at high-risk for lung cancer. However, the impact 
of beta carotene treatment on mortality in patients across the spectrum of cardiovascular 
risk has not been well-studied. Therefore, we performed a pooled analysis of randomized 
trials of beta carotene therapy in both low-risk and high-risk patients. 
Methods: We pooled the results of four trials which randomized patients to either beta 
carotene or control therapy. Only trials which included 1000 or more patients were 
included in the analysis. The dose of beta carotene ranged from 20mg to 50mg. 
Results: Four trials, enrolling 90,054 patients fulfilled the inclusion criteria. The pooled 
, all-cause mortality rate was 10.5% in the beta-carotene arm and 9.9% in the control arm. 
The odds ratio of death for patients treated with beta carotene was 1.07 (1.02. 
1.12;P=O.O03). The rate of death from cardiovascular causes was 4.9% in the beta caro- 
tene group and 4.5% in the control therapy group. The odds ratio for cardiovascular 
death with beta carotene therapy was 1.1 (1.03-1.17; P=O.O03). There were no signifi- 
cant differences in rate of cerebrovascular accident between patients treated with beta 
carotene and those treated with control therapy (4.1% vs. 4.2%, respectively; P=O.59). 
The Breslow-Day test for homogeneity of the odds ratios was not significant (P=O.26). 
Conclusion: Supplementation with beta carotene is associated with a significant 
I increase in all-cause mortality and cardiovascular death in patients at risk for coronary disease. The risk of death from beta carotene therapy appears strongest I” smokers. 
However, a trend towards harm with beta carotene treatment was found even in low-risk 
patients. The adverse effect of beta carotene treatment on all-cause mortality was found 
_. 
Methods: The OPUS-TIM1 16 trial included 10,266 ACS patients at 753 sites in 28 coun- 
tries. Of these patients, 1246 (12.1%) came from 62 sites in the EE countries of the 
Czech Republic, Hungary, Poland, and Russia. Pabents received adjuvant treatments at 
physician discretion. We compared variation in baseline characteristics, treatment, and 
outcomes of patients in EE and other regions of the world (RW). 
Results: We found that EE patients in OPUS-TIM1 16 had more high-risk features at pre- 
sentation. We identified significant variation between EE and other regions in use of adju- 
vant therapies during hospitalization. While only 22.5% of EE patients received 
hypolipidemics versus 39.9% of patients in RW (pcO.OOl), we observed more extensive 
use of angiotensin converting enzyme inhibitors (56.3 versus 36.7 (P<O.OOl)), beta- 
blockers (65.3 versus 46.62 (P<O.OOl)), calcium-channel blockers (6.22 versus 3.92 
(PcO.OOl), and nitrates (64.9 versus 26.8 (P<O.OOl)) in EE. EE patients also underwent 
fewer percutaneous coronary interventions (PCI) (11.66% versus 29.93% (P<O.OOl). 
Patients !n EE had worse outcomes at 30 days. After adjustment for baseline characteris- 
tics and revascularization rates, EE patients had higher rates of death (hazard ratio (HR) 
1.82 (P=O.OOS)). and myocardial infarction (HR 1.64 (P=O.OOl)). These trends persisted 
at 10 months. 
Conclusion: Despite similarities in ACS management guidelines, this study revealed 
disparities in use of hypolipidemic agents and PCI between EE sites and RW in a large 
multinational clinical trial. Given the higher rates of adjusted mortality and myocardial inf- 
arction among EE patients, these findings indicate the need for studies to address the 
sources of treatment and outcome variation, and strategies for improving access to effec- 
tive cardiovascular therapies in EE. 
1193-52 Troponin I Elevation Following Percutaneous Coronary 
Intervention Does Not Predict Future Adverse 
Outcomes 
J. William Phillips, Habib Samady, Linda Snyder, Robert H. Christenson, Jennifer 
Gibson, David E. Bruns, Sharon Sayre. Lawrence W. Gimple. Michael Rag&a, Eric R. 
Powers, Ian J. Sarembock, University of Virginia, Charlottesville, VA 
Background: The importance of troponin I (cTnl) elevation following percutaneous coro- 
narv interventions (PCI) has not been evaluated as extensivelv as CK-MB. This studv 
evaluated the prognostic significance of cTnl elevation following PCI on MACE (death, 
MI, TVR) at three years. 
Methods: We prospectively studied 320 consecutive patients without acute MI who 
underwent successful PCI (mean age 62 +/- 12, males 64%, diabetes 32%. prior Ml 43%, 
CHF 12%, stent use 76%). All patients had blood drawn before and 12-24 hours after 
PCI for cTnl assay on a Dimension @ RxL. Serial follow-up by phone and questionnaire 
occurred at six months. one. two and three “ears. 
Results: Periprocedural cTnl elevation occurred in 192/320 (60%) patients using cTnl > 
0.1 na/mL. Usina cTnl 2 1.5 na/mL elevation occurred in 701320 (22%). a rate similar to 
other studies with CK-MB. Patients with periprocedural elevation of cTnl 2 0.1 ng/mL had 
similar rates of death (9% Versus IO%, p=ns), death and Ml (15% Versus 16%, p=ns) or 
any MACE (33% Versus 32%, p=ns) at 3 years. After controoling for other variables, by 
multivariable logistic regression analysis, cTnl as a continuous variable after PCI was not 
a significant predictor of death (x2 2.7, p=O.lO), death and Ml (x2 1.9, p=O.l7), or death, 
MI, and lVR (x2 0.0, p=O.96) at three years. 
Conclusion: After control for common variables, cTnl elevation following PCI does not 
add prognostic information about future MACE for up to 3 years post-PCI. This may be 
due to a higher sensitivity of cTnl to detect small amounts of myocardial injury that are 
not associated with worse long-term outcomes. This has important implications for the 
design of clinical trials and suggests against the use of cTnl elevation following PCI as a 
primary endpoint. 
